Hemogenyx Pharmaceuticals Share Discussion Threads

[purple11] 19/1/2020 13:35

look at the numbers on this car-t phase 1 collaboration today, incl. €45m upfront, to put it into context hemo has a current mcap of 8m

[purple11] 19/1/2020 13:29

interesting post,the big gains lie ahead.

scaramouche1941
15 Jan '20 - 21:03 - 3485 of 3486
0 1 0
As far as I know a normal progression in the drug development is 1. Target identification, 2. Target validation, 3. Molecule (antibody discovery, cell construction etc)design, 4. in vitro efficacy, 5. in vivo efficacy, 6. IND-enabling studies, 7. IND, 8. Clinical trials
It looks like Hemo went to IND enabling studies with their antibody and now they are repeating the same with CAR T.
I am impressed! All this for the money they raised when listed two years ago?!? This is crazy

[purple11] 19/1/2020 13:25

its great that there is more than one globalco collaborating with HEMO as it gives HEMO far better negotiating power going and a far greater chance of a great deal going forward.all super exciting now imo.

[shukan] 19/1/2020 09:55

Hemo collaborates with two Nasdaq pharma CDX-ANTI BODIES AND CAR-T
their mouse models outlive other pharma humanised mice as they die within a six week time frame, so there is a need for Hemo mice for longer term testing with pharma hence the interest, watch this space for a major update as the doors open to Hemogenyx.
PR will be on the forefront in 2020 as presently it is woeful-
Lilly are not involved with CAR-T there is a third Global pharma involved watch for that update.

All in all a very exciting news rich period for Hemogenyx and long suffering shareholders - small free float difficult to buy in quantity as we have seen with the latest 30% rise.

[purple11] 17/1/2020 13:13

"In a presentation to investors this week, Lilly Chief Executive David Ricks said most of its deals will be in the cancer space, but that other therapeutic areas remain of strong interest as well.

While the company is still looking at late-stage assets, Smiley said the most opportunity for shareholders is in drugs in earlier stages of development.

Deals could include licensing agreements, outright acquisitions, or other structures, he added."


I pretty sure lilly are the globalco we're in development with.too many hints....

[purple11] 16/1/2020 19:18

Vladislav Sandler
@vmsandler
It feels that #JPM2020 and it’s satellite #BiotechShowcase were the most productive for smaller agile companies looking for deals and partners. I am looking to 2020 with a lot of optimism and anticipation!

[purple11] 16/1/2020 09:18

you wont be seeing iamgreat here again.complete nutjob

[iamgreat1] 16/1/2020 09:12

Told you people yesterday to book those profits But didn't listen Now down it goes like mph

[marie1980] 16/1/2020 09:09

Spot on Purple.
NFX was around 2p for like 2 years and then it jumped like X4.
Let’s see update about JPM conference.

[purple11] 16/1/2020 08:55

I agree this is not the time to be losing your holding.we are moving into the interesting period now.

expecting an NFX type move later in the year.happy to wait for it.gl

[tsmith2] 16/1/2020 08:49

There's a stacks of news to come this year and it will be transformational

[purple11] 16/1/2020 08:46

interesting post,the big gains lie ahead.

scaramouche1941
15 Jan '20 - 21:03 - 3485 of 3486
0 1 0
As far as I know a normal progression in the drug development is 1. Target identification, 2. Target validation, 3. Molecule (antibody discovery, cell construction etc)design, 4. in vitro efficacy, 5. in vivo efficacy, 6. IND-enabling studies, 7. IND, 8. Clinical trials
It looks like Hemo went to IND enabling studies with their antibody and now they are repeating the same with CAR T.
I am impressed! All this for the money they raised when listed two years ago?!? This is crazy

[delano1967] 15/1/2020 19:46

That should read ..... pointless deramping/bashing here....

[delano1967] 15/1/2020 19:43

Remember this is not your normal PLC, it’s a team of scientists/miracle workers. That’s what makes this a share for only true investors that understand that you can own 1,000’s of shares now that could be worth £1,000’s in years to come. Pointless dreaming here... move on! GLA to true understanding investors in this story.

[johntopdog] 15/1/2020 19:25

Weren't you going to buy when it went down to low 2's....but never did...I can see why you are annoyed..

Go back to CTEA forum..they miss you there...we don't...

[texaschaser] 15/1/2020 19:23

Iamgreat1 aka @thelongergame aka ZM19 on LSE Aka jammydodger (stopped posting on 6th December set up iamgreat1 on 6th December and ZM19 on LSE 8th December Deramps under one name pumps on other names

[davevt] 15/1/2020 19:21

Have I ever been wrong so far?

Never.

Look at all the sells piling in at the end of the day...

[johntopdog] 15/1/2020 18:55

That's upset davevt today...3 posts...poor chap

[davevt] 15/1/2020 18:51

Yet another 'in vitro' result...

Investors are still waiting 2 years on for anything from the first in vitro results, if anything ever happens at all.

Even today's result is years away from fruition. Next step from in vitro, is then testing in mice.

Serious deja vu.

Back down to sub 2s again it seems.

[purple11] 15/1/2020 18:24

hopefully investors will use this thread.the other threads are getting ruined by idiots.

[iamgreat1] 15/1/2020 14:26

Remember what happened to mph sell while u can before it goes back down again

[tsmith2] 15/1/2020 13:04

This is going to a big big winner